That's in addition to $450M they got from Abbott in 2010. http://www.reatapharma.com/investors-media/news/news-timeline/2010/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-bardoxolone-methyl-for-chronic-kidney-disease-outside-the-us.aspx